Carlos Ferreira

Dr. Carlos Ferreira went to medical school at the National University of Asunción, completed an Internal Medicine residency at Rush University Medical Center in Chicago (2009-2012), a fellowship in Clinical Genetics at the NHGRI and Johns Hopkins Hospital Medical Genetics consortium (2012-2014), and a subspecialty in medical biochemical genetics at NHGRI (2015). From 2015 to 2018, he worked as an attending physician in the Division of Genetics and Metabolism at Children’s National Medical Center. As an appointee of the Physician Scientist Development Program at the National Human Genome Research Institute (NHGRI) in 2019, he established the Skeletal Genomics Unit and began a translational research program to uncover the natural history of skeletal disorders, create cell and animal models to dissect their pathomechanisms, and develop novel therapeutic strategies. Since 2024, he has led the Unit on Skeletal Genomics at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Dr. Ferreira serves as an editor for three biomedical journals and participates as faculty in the prestigious annual course on skeletal dysplasias. In 2019 he was awarded the Exceptional Didactic Teaching Award, and in 2025 the Suzanne Hart Award for Outstanding Teaching in Medical Genetics bestowed by genetics trainees. Dr. Ferreira serves as co-chair of the Skeletal Disorders Clinical Domain Working Group, and co-chair of the Skeletal Disorders Gene Curation Expert Panel of the Clinical Genome Resource (ClinGen), whose purpose is to create an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. He also serves as the President of the International Skeletal Dysplasia Society (ISDS), whose mission is to promote scientific progress to advance knowledge and patient care in the field of genetic disorders of bone and cartilage. In 2019, Dr. Ferreira received the Emmanuel Shapira Award bestowed to the best paper published in Molecular Genetics and Metabolism, while in 2024 he received the GACI Global Hope Award bestowed by individuals and families affected by Generalized Arterial Calcification of Infancy (GACI).